Literature DB >> 10728034

Effectiveness of BCG vaccination against tuberculous meningitis.

S Awasthi1, S Moin.   

Abstract

OBJECTIVE: To assess the protective effectiveness of BCG vaccination against tuberculous meningitis, while controlling for age, nutrition and socio-economic status, in children 1 month to 12 years of age.
DESIGN: Case-control study.
SETTING: Secondary care referral and teaching hospital.
METHODS: Cases were those conforming to the definition of tuberculous meningitis and controls were patients admitted after every third consecutive case included in the study from September 1995 till the end of August 1997 and who did not suffer from any central nervous system disorder.
RESULTS: Among the 192 cases and 70 controls, BCG scar was present in 57.8% and 75.7%, respectively. The crude odd's ratio (OR)for tuberculosis meningitis with a BCG scar was 0.44 (95% CI, .24-0.81; p = 0.008), while the adjusted OR was 0.53 (95% CI, 0.26-1.06; p value = 0.07) after controlling for weight, age, sex and place of residence. Higher weight for age and urban residence were associated with a decreased risk of tuberculous meningitis in the logistic model.
CONCLUSIONS: BCG vaccination offers protection against tuberculous meningitis. Since improvement in weight for age was associated with a decreased risk of disease, further studies are needed to evaluate the association, if any, between nutritional status and vaccine efficacy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10728034

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  8 in total

Review 1.  Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

Review 2.  Does neonatal BCG vaccination protect against tuberculous meningitis?

Authors:  V Walker; G Selby; I Wacogne
Journal:  Arch Dis Child       Date:  2006-09       Impact factor: 3.791

3.  Serial study of clinical and CT changes in tuberculous meningitis.

Authors:  P Ranjan; J Kalita; U K Misra
Journal:  Neuroradiology       Date:  2003-04-10       Impact factor: 2.804

4.  Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring.

Authors:  Janine Jason; Lennox K Archibald; Okey C Nwanyanwu; Peter N Kazembe; Julie A Chatt; Elizabeth Norton; Hamish Dobbie; William R Jarvis
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 5.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

6.  Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis.

Authors:  Jingyu Mu; Mangalakumari Jeyanathan; Cherrie-Lee Small; Xizhong Zhang; Elizabeth Roediger; Xueya Feng; Duncan Chong; Jack Gauldie; Zhou Xing
Journal:  Mol Ther       Date:  2009-03-24       Impact factor: 11.454

Review 7.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

Review 8.  Bacillus Calmette-Guerin (BCG): the adroit vaccine.

Authors:  Oluwafolajimi A Adesanya; Christabel I Uche-Orji; Yeshua A Adedeji; John I Joshua; Adeniyi A Adesola; Chibuike J Chukwudike
Journal:  AIMS Microbiol       Date:  2021-02-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.